Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1009

1.

Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).

Ohta T, Kato T, Kawakami H, Miyake Y, Goto M, Iwamoto S, Otsuji T, Nakamura M, Sugimoto N, Okamura S, Kotaka M, Tsujie M, Tokunaga Y, Mishima H, Hata T, Shimokawa T, Kurokawa Y, Satoh T.

Int J Clin Oncol. 2020 Mar 26. doi: 10.1007/s10147-020-01656-3. [Epub ahead of print]

PMID:
32219630
2.

GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.

Fujiyama H, Tsuji T, Hironaka K, Yoshida K, Sugimoto N, Fujita M.

J Biochem. 2020 Jan 1;167(1):15-24. doi: 10.1093/jb/mvz075.

PMID:
32193559
3.

Thermal structure of the Venusian atmosphere from the sub-cloud region to the mesosphere as observed by radio occultation.

Ando H, Imamura T, Tellmann S, Pätzold M, Häusler B, Sugimoto N, Takagi M, Sagawa H, Limaye S, Matsuda Y, Choudhary RK, Antonita M.

Sci Rep. 2020 Feb 26;10(1):3448. doi: 10.1038/s41598-020-59278-8.

4.

Thrombin binding aptamer G-quadruplex stabilized by pyrene-modified nucleotides.

Kovačič M, Podbevšek P, Tateishi-Karimata H, Takahashi S, Sugimoto N, Plavec J.

Nucleic Acids Res. 2020 Feb 25. pii: gkaa118. doi: 10.1093/nar/gkaa118. [Epub ahead of print]

PMID:
32095808
5.

A phase 2 study of capecitabine plus oxaliplatin therapy (XELOX) for patients with inoperable/advanced gastric cancer who were resistant/intolerable to fluoropyrimidine, CDDP, taxane, and CPT-11 (OGSG1403).

Kawada J, Sugimoto N, Hirokazu T, Ueda S, Murakami K, Nishikawa K, Kurokawa Y, Fujitani K, Kawakami H, Sakai D, Shimokawa T, Satoh T.

Ann Oncol. 2019 Jul;30 Suppl 4:iv49. doi: 10.1093/annonc/mdz155.179. Epub 2019 Dec 4. No abstract available.

6.

Hydroxyl groups in cosolutes regulate the G-quadruplex topology of telomeric DNA.

Tateishi-Karimata H, Banerjee D, Ohyama T, Matsumoto S, Miyoshi D, Nakano SI, Sugimoto N.

Biochem Biophys Res Commun. 2020 Feb 18. pii: S0006-291X(20)30313-2. doi: 10.1016/j.bbrc.2020.02.045. [Epub ahead of print]

PMID:
32081425
7.

Preferential targeting cancer-related i-motif DNAs by the plant flavonol fisetin for theranostics applications.

Takahashi S, Bhattacharjee S, Ghosh S, Sugimoto N, Bhowmik S.

Sci Rep. 2020 Feb 13;10(1):2504. doi: 10.1038/s41598-020-59343-2.

8.

New Modified Deoxythymine with Dibranched Tetraethylene Glycol Stabilizes G-Quadruplex Structures.

Tateishi-Karimata H, Ohyama T, Muraoka T, Tanaka S, Kinbara K, Sugimoto N.

Molecules. 2020 Feb 6;25(3). pii: E705. doi: 10.3390/molecules25030705.

9.

Chemical biology of non-canonical structures of nucleic acids for therapeutic applications.

Tateishi-Karimata H, Sugimoto N.

Chem Commun (Camb). 2020 Feb 25;56(16):2379-2390. doi: 10.1039/c9cc09771f. Review.

PMID:
32022004
10.

Salivary Immunoglobulin A Secretion and Polymeric Ig Receptor Expression in the Submandibular Glands Are Enhanced in Heat-Acclimated Rats.

Matsuzaki K, Sugimoto N, Islam R, Hossain ME, Sumiyoshi E, Katakura M, Shido O.

Int J Mol Sci. 2020 Jan 27;21(3). pii: E815. doi: 10.3390/ijms21030815.

11.

Effect of Potassium Concentration on Triplex Stability under Molecular Crowding Conditions.

Teng Y, Tateishi-Karimata H, Ohyama T, Sugimoto N.

Molecules. 2020 Jan 17;25(2). pii: E387. doi: 10.3390/molecules25020387.

12.

[Quantitative Analysis of Piperine and the Derivatives in Long Pepper Extract by HPLC Using Relative Molar Sensitivity].

Mizumoto T, Nakano F, Nishizaki Y, Masumoto N, Sugimoto N.

Shokuhin Eiseigaku Zasshi. 2019;60(5):134-143. doi: 10.3358/shokueishi.60.134. Japanese.

13.

Comparison of cytologic findings between specimens with and without high-risk HPV infection in those with ASC-US judgement.

Kuramoto H, Banno M, Sugimoto N, Sugahara T, Kato C, Hori M, Kimura A.

Hum Cell. 2020 Apr;33(2):397-404. doi: 10.1007/s13577-019-00307-8. Epub 2020 Jan 14.

PMID:
31939005
14.

Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials.

Yoshino T, Cleary JM, Van Cutsem E, Mayer RJ, Ohtsu A, Shinozaki E, Falcone A, Yamazaki K, Nishina T, Garcia-Carbonero R, Komatsu Y, Baba H, Argilés G, Tsuji A, Sobrero A, Yamaguchi K, Peeters M, Muro K, Zaniboni A, Sugimoto N, Shimada Y, Tsuji Y, Hochster HS, Moriwaki T, Tran B, Esaki T, Hamada C, Tanase T, Benedetti F, Makris L, Yamashita F, Lenz HJ.

Ann Oncol. 2020 Jan;31(1):88-95. doi: 10.1016/j.annonc.2019.10.005.

15.

Laparoscopic resection of abdominal cystic lymphangioma derived from lesser omentum: Case report.

Hamaguchi Y, Arita S, Sugimoto N, Inamoto O, Takagi H, Kogire M, Kitai T.

Medicine (Baltimore). 2020 Jan;99(1):e18641. doi: 10.1097/MD.0000000000018641.

16.

Smaller anterior subgenual cingulate volume mediates the effect of girls' early sexual maturation on negative psychobehavioral outcome.

Okada N, Yahata N, Koshiyama D, Morita K, Sawada K, Kanata S, Fujikawa S, Sugimoto N, Toriyama R, Masaoka M, Koike S, Araki T, Kano Y, Endo K, Yamasaki S, Ando S, Nishida A, Hiraiwa-Hasegawa M, Kasai K.

Neuroimage. 2020 Apr 1;209:116478. doi: 10.1016/j.neuroimage.2019.116478. Epub 2019 Dec 26.

17.

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity.

Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, Akasaka M, Nakamura S, Higashi N, Xu H, Matsumoto T, Fujio K, Manz MG, Hotta A, Takizawa H, Eto K, Sugimoto N.

Stem Cell Reports. 2020 Jan 14;14(1):49-59. doi: 10.1016/j.stemcr.2019.11.011. Epub 2019 Dec 26.

18.

Spherulitic Crystallization in Langmuir-Blodgett Films of the Ditetradecyldimethylammonium-Au(dmit)2 Salt.

Miura YF, Akiyama H, Sugimoto N, Akagi Y, Aoyama T, Shiroishi H, Takahashi M.

Langmuir. 2020 Jan 21;36(2):554-562. doi: 10.1021/acs.langmuir.9b03677. Epub 2020 Jan 7.

PMID:
31867973
19.

Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.

Moriwaki T, Fukuoka S, Masuishi T, Takashima A, Kumekawa Y, Kajiwara T, Yamazaki K, Esaki T, Makiyama A, Denda T, Hatachi Y, Suto T, Sugimoto N, Enomoto M, Ishikawa T, Kashiwada T, Oki E, Komatsu Y, Tsuji A, Tsuchihashi K, Sakai D, Ueno H, Tamura T, Yamashita K, Shimada Y.

Int J Clin Oncol. 2019 Dec 14. doi: 10.1007/s10147-019-01600-0. [Epub ahead of print]

PMID:
31838590
20.

Sub-Chronic Consumption of Dark Chocolate Enhances Cognitive Function and Releases Nerve Growth Factors: A Parallel-Group Randomized Trial.

Sumiyoshi E, Matsuzaki K, Sugimoto N, Tanabe Y, Hara T, Katakura M, Miyamoto M, Mishima S, Shido O.

Nutrients. 2019 Nov 16;11(11). pii: E2800. doi: 10.3390/nu11112800.

21.

Use of social networking sites and desire for slimness among 10-year-old girls and boys: A population-based birth cohort study.

Sugimoto N, Nishida A, Ando S, Usami S, Toriyama R, Morimoto Y, Koike S, Yamasaki S, Kanata S, Fujikawa S, Furukawa TA, Sasaki T, Hiraiwa-Hasegawa M, Kasai K.

Int J Eat Disord. 2020 Feb;53(2):288-295. doi: 10.1002/eat.23202. Epub 2019 Nov 19.

PMID:
31743492
22.

Identification of candidate molecular targets of the novel antineoplastic antimitotic NP-10.

Yokoyama T, Yukuhiro M, Iwasaki Y, Tanaka C, Sankoda K, Fujiwara R, Shibuta A, Higashi T, Motoyama K, Arima H, Yoshida K, Sugimoto N, Morimoto H, Kosako H, Ohshima T, Fujita M.

Sci Rep. 2019 Nov 14;9(1):16825. doi: 10.1038/s41598-019-53259-2.

23.

[PREVALENCE OF FUNCTIONAL DYSPEPSIA SYMPTOMS IN PATIENTS WITH ASTHMA].

Tomyo F, Sugimoto N, Toyota H, Ito A, Ujino M, Sakasegawa H, Kobayashi K, Koizumi Y, Miyoshi S, Kuramochi M, Yamaguchi M, Yamamoto T, Nagase H.

Arerugi. 2019;68(9):1132-1140. doi: 10.15036/arerugi.68.1132. Japanese.

PMID:
31723110
24.

[Reconstitution of the hematopoietic system and clinical applications of iPS cells].

Sugimoto N, Eto K.

Rinsho Ketsueki. 2019;60(9):1046-1055. doi: 10.11406/rinketsu.60.1046. Review. Japanese.

PMID:
31597826
25.

GRWD1 directly interacts with p53 and negatively regulates p53 transcriptional activity.

Fujiyama H, Tsuji T, Hironaka K, Yoshida K, Sugimoto N, Fujita M.

J Biochem. 2020 Jan 1;167(1):15-24. doi: 10.1093/jb/mvz075.

PMID:
31545368
26.

Variation in accumulated dose of volumetric-modulated arc therapy for pancreatic cancer due to different beam starting phases.

Sasaki M, Nakamura M, Mukumoto N, Goto Y, Ishihara Y, Nakata M, Sugimoto N, Mizowaki T.

J Appl Clin Med Phys. 2019 Oct;20(10):118-126. doi: 10.1002/acm2.12720. Epub 2019 Sep 20.

27.

In situ condensation of an anti-cancer drug into fibrin gel enabling effective inhibition of tumor cell growth.

Kuwahara M, Fujita H, Kataoka Y, Nakajima Y, Yamada M, Sugimoto N.

Chem Commun (Camb). 2019 Oct 7;55(78):11679-11682. doi: 10.1039/c9cc06418d. Epub 2019 Sep 16.

PMID:
31524892
28.

Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.

Hamaguchi T, Denda T, Kudo T, Sugimoto N, Ura T, Yamazaki K, Fujii H, Kajiwara T, Nakajima TE, Takahashi S, Otsu S, Komatsu Y, Nagashima F, Moriwaki T, Esaki T, Sato T, Itabashi M, Oki E, Sasaki T, Chiron M, Yoshino T.

Cancer Sci. 2019 Nov;110(11):3565-3572. doi: 10.1111/cas.14198. Epub 2019 Oct 21.

29.

Measurement of water mist particle size generated by rocket launch using a two-wavelength multi-static lidar.

Jin Y, Sugimoto N, Nishizawa T, Yoshitomi T, Sawada A, Sarae W, Hattori A, Yamasaki Y, Okamoto H, Sato K.

Appl Opt. 2019 Aug 10;58(23):6274-6279. doi: 10.1364/AO.58.006274.

PMID:
31503770
30.

Stabilization of DNA Loop Structures by Large Cations.

Nakano SI, Ayusawa T, Tanino Y, Sugimoto N.

J Phys Chem B. 2019 Sep 12;123(36):7687-7694. doi: 10.1021/acs.jpcb.9b06074. Epub 2019 Aug 29.

PMID:
31465227
31.

A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week).

Nanke Y, Kobashigawa T, Sugimoto N, Yamanaka H, Kotake S.

Immunol Med. 2019 Jun;42(2):99-102. doi: 10.1080/25785826.2019.1657255. Epub 2019 Aug 25.

PMID:
31446856
32.

Quantitative Analysis of Stall of Replicating DNA Polymerase by G-Quadruplex Formation.

Takahashi S, Sugimoto N.

Methods Mol Biol. 2019;2035:257-274. doi: 10.1007/978-1-4939-9666-7_15.

PMID:
31444755
33.

Corticosterone inhibits the expression of cannabinoid receptor-1 and cannabinoid receptor agonist-induced decrease in cell viability in glioblastoma cells.

Sugimoto N, Ishibashi H, Ueda Y, Nakamura H, Yachie A, Ohno-Shosaku T.

Oncol Lett. 2019 Aug;18(2):1557-1563. doi: 10.3892/ol.2019.10456. Epub 2019 Jun 7.

34.

Surgical management for peritoneal carcinomatosis of appendiceal origin with a high-tumor burden.

Kitai T, Yamanaka K, Sugimoto N, Inamoto O.

Surg Today. 2020 Feb;50(2):171-177. doi: 10.1007/s00595-019-01856-z. Epub 2019 Jul 30.

PMID:
31363844
35.

Sex differences in the safety of S-1 plus oxaliplatin and S-1 plus cisplatin for patients with metastatic gastric cancer.

Yamada Y, Koizumi W, Nishikawa K, Gotoh M, Fuse N, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Hyodo I.

Cancer Sci. 2019 Sep;110(9):2875-2883. doi: 10.1111/cas.14117. Epub 2019 Jul 23.

36.

Optimization and characterization of red pigment production from an endophytic fungus, Nigrospora aurantiaca CMU-ZY2045, and its potential source of natural dye for use in textile dyeing.

Suwannarach N, Kumla J, Nishizaki Y, Sugimoto N, Meerak J, Matsui K, Lumyong S.

Appl Microbiol Biotechnol. 2019 Sep;103(17):6973-6987. doi: 10.1007/s00253-019-09926-5. Epub 2019 Jun 26.

PMID:
31243502
37.

Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide.

Yamamoto K, Kitawaki T, Sugimoto N, Fujita H, Kawase Y, Takaori-Kondo A, Kadowaki N.

Immunol Lett. 2019 Jul;211:41-48. doi: 10.1016/j.imlet.2019.05.012. Epub 2019 May 26.

PMID:
31141702
38.

Conformational Dynamics of the RNA G-Quadruplex and its Effect on Translation Efficiency.

Endoh T, Sugimoto N.

Molecules. 2019 Apr 24;24(8). pii: E1613. doi: 10.3390/molecules24081613.

39.

Determination of perillaldehyde in perilla herbs using relative molar sensitivity to single-reference diphenyl sulfone.

Masumoto N, Nishizaki Y, Maruyama T, Igarashi Y, Nakajima K, Yamazaki T, Kuroe M, Numata M, Ihara T, Sugimoto N, Sato K.

J Nat Med. 2019 Jun;73(3):566-576. doi: 10.1007/s11418-019-01306-7. Epub 2019 Apr 23.

PMID:
31016636
40.

Theobromine Improves Working Memory by Activating the CaMKII/CREB/BDNF Pathway in Rats.

Islam R, Matsuzaki K, Sumiyoshi E, Hossain ME, Hashimoto M, Katakura M, Sugimoto N, Shido O.

Nutrients. 2019 Apr 20;11(4). pii: E888. doi: 10.3390/nu11040888.

41.

αIIbβ3 changes gears in MKs and platelets.

Sugimoto N, Eto K.

Blood. 2019 Apr 18;133(16):1700-1701. doi: 10.1182/blood-2019-01-896092. No abstract available.

PMID:
31000515
42.

Identification, characterization, and structural analyses of a fungal endo-β-1,2-glucanase reveal a new glycoside hydrolase family.

Tanaka N, Nakajima M, Narukawa-Nara M, Matsunaga H, Kamisuki S, Aramasa H, Takahashi Y, Sugimoto N, Abe K, Terada T, Miyanaga A, Yamashita T, Sugawara F, Kamakura T, Komba S, Nakai H, Taguchi H.

J Biol Chem. 2019 May 10;294(19):7942-7965. doi: 10.1074/jbc.RA118.007087. Epub 2019 Mar 29.

PMID:
30926603
43.

A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.

Nishikawa K, Murotani K, Fujitani K, Inagaki H, Akamaru Y, Tokunaga S, Takagi M, Tamura S, Sugimoto N, Shigematsu T, Yoshikawa T, Ishiguro T, Nakamura M, Hasegawa H, Morita S, Miyashita Y, Tsuburaya A, Sakamoto J, Tsujinaka T.

Cancer Chemother Pharmacol. 2019 May;83(5):867-874. doi: 10.1007/s00280-019-03802-9. Epub 2019 Feb 26.

PMID:
30806758
44.

RNA-Capturing Microsphere Particles (R-CAMPs) for Optimization of Functional Aptamers.

Endoh T, Ohyama T, Sugimoto N.

Small. 2019 Jun;15(26):e1805062. doi: 10.1002/smll.201805062. Epub 2019 Feb 18.

PMID:
30773785
45.

Validation of the nearest-neighbor model for Watson-Crick self-complementary DNA duplexes in molecular crowding condition.

Ghosh S, Takahashi S, Endoh T, Tateishi-Karimata H, Hazra S, Sugimoto N.

Nucleic Acids Res. 2019 Apr 23;47(7):3284-3294. doi: 10.1093/nar/gkz071.

46.

Allergy to carminic acid: in vitro evidence of involvement of protein-binding hapten.

Osumi M, Yamaguchi M, Sugimoto N, Suzukawa M, Arai H, Akiyama H, Nagase H, Ohta K.

Asia Pac Allergy. 2019 Jan 14;9(1):e2. doi: 10.5415/apallergy.2019.9.e2. eCollection 2019 Jan.

47.

Bisubstrate Function of RNA Polymerases Triggered by Molecular Crowding Conditions.

Takahashi S, Okura H, Sugimoto N.

Biochemistry. 2019 Feb 26;58(8):1081-1093. doi: 10.1021/acs.biochem.8b01204. Epub 2019 Feb 15.

PMID:
30714721
48.

Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.

Ujino M, Miyoshi S, Sugimoto N, Arai H, Ota Y, Sasajima Y, Kawamura M, Nagase H, Yamaguchi M, Ohta K.

Intern Med. 2019 Jun 15;58(12):1759-1764. doi: 10.2169/internalmedicine.2080-18. Epub 2019 Feb 1.

49.

Neurometabolic and functional connectivity basis of prosocial behavior in early adolescence.

Okada N, Yahata N, Koshiyama D, Morita K, Sawada K, Kanata S, Fujikawa S, Sugimoto N, Toriyama R, Masaoka M, Koike S, Araki T, Kano Y, Endo K, Yamasaki S, Ando S, Nishida A, Hiraiwa-Hasegawa M, Edden RAE, Barker PB, Sawa A, Kasai K.

Sci Rep. 2019 Jan 24;9(1):732. doi: 10.1038/s41598-018-38355-z.

50.

Heat attenuates sensitivity of mammalian cells to capsaicin.

Sugimoto N, Matsuzaki K, Katakura M, Nakamura H, Ueda Y, Yachie A, Shido O.

J Biochem Mol Toxicol. 2019 May;33(5):e22288. doi: 10.1002/jbt.22288. Epub 2019 Jan 23.

PMID:
30672650

Supplemental Content

Loading ...
Support Center